Immunocompromised individuals are at high risk for herpes zoster caused by reactivation of varicella zoster virus (VZV). Long-lasting pain, vision loss, encephalitis, dissemination, recurrence and persistence cause significant morbidity in AIDS patients and greatly impact their quality of life. Current treatments with acyclovir and its derivatives have met with some success, but pain and other sequelae often persist despite therapy. Research into new treatments that stop the spread of HZ lesions may reduce the suffering from complications that continue to place a burden on AIDS patients, their caregivers, and on society. A novel approach to preventing VZV replication is to treat the host cell with compounds that inhibit cyclin-dependent kinases, causing cell cycle arrest and blocking VZV growth. The primary hypothesis is that VZV replication is dependent on the activity of cellular and/or viral kinases that are targets of cdk inhibitors. The goals of this proposal are to test the antiviral effects of the drugs in cell models and in an animal model of VZV replication and ultimately describe the mechanisms whereby cdk inhibitor drugs render cells nonpermissive for VZV replication.
The first aim i s to evaluate the ability of cdk inhibitors to block VZV replication in vitro. Roscovitine, purvalanol, and flavopiridol are three cdk inhibitors that cause cell-cycle arrest and will be tested for their ability to block VZV growth in cell culture.
The second aim i s to evaluate the ability of cdk inhibitors to block VZV replication in vivo. Human skin explants and the SCID-hu mouse implanted with human skin or thymus/liver tissues (a source of T cells) will be used to study the effects of cdk inhibitors on VZV replication.
The third aim i s to define the molecular mechanisms of cdk inhibition of VZV replication. The effects of VZV infection on cell cycle regulatory components will be studied and the proteins involved in these interactions will be identified. This proposal is designed to address at the molecular level how cdk inhibitors prevent VZV replication in vitro and in vivo. Understanding precisely how cdk inhibitors block VZV growth is the starting point for development of effective antiviral agents. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052168-05
Application #
7195706
Study Section
Virology Study Section (VR)
Program Officer
Dempsey, Walla L
Project Start
2003-03-01
Project End
2009-02-28
Budget Start
2007-03-01
Budget End
2009-02-28
Support Year
5
Fiscal Year
2007
Total Cost
$252,217
Indirect Cost
Name
Upstate Medical University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Chen, Kevin G; Sikic, Branimir I (2012) Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 18:1863-9
Moffat, Jennifer F; Greenblatt, Rebecca J (2010) Effects of varicella-zoster virus on cell cycle regulatory pathways. Curr Top Microbiol Immunol 342:67-77
Rowe, Jenny; Greenblatt, Rebecca J; Liu, Dongmei et al. (2010) Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice. Antiviral Res 86:276-85
Leisenfelder, Stacey A; Kinchington, Paul R; Moffat, Jennifer F (2008) Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions. J Virol 82:12116-25
Zhang, Zhen; Rowe, Jenny; Wang, Weijia et al. (2007) Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol 81:9024-33
Zapata, Heidi J; Nakatsugawa, Masako; Moffat, Jennifer F (2007) Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J Virol 81:977-90
Leisenfelder, Stacey A; Moffat, Jennifer F (2006) Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity. J Virol 80:5577-87
Wang, Weijia; Taylor, Shannon L; Leisenfelder, Stacey A et al. (2005) Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice. J Virol 79:2115-23
Taylor, Shannon L; Moffat, Jennifer F (2005) Replication of varicella-zoster virus in human skin organ culture. J Virol 79:11501-6
Taylor, Shannon L; Kinchington, Paul R; Brooks, Andrew et al. (2004) Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. J Virol 78:2853-62

Showing the most recent 10 out of 11 publications